Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia
Source: Blood - Category: Hematology Authors: Vogiatzi, F., Winterberg, D., Lenk, L., Buchmann, S., Cario, G., Schrappe, M., Peipp, M., Richter-Pechanska, P., Kulozik, A. E., Lentes, J., Bergmann, A. K., Valerius, T., Frielitz, F.-S., Kellner, C., Schewe, D. M. Tags: Pediatric Hematology, Lymphoid Neoplasia Letter to Blood Source Type: research